Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Year range
1.
Rev. méd. Minas Gerais ; 23(4)out.-dez. 2013.
Article in Portuguese | LILACS | ID: lil-704939

ABSTRACT

Antes da introdução da terapia antirretroviral de alta potência, as complicações cardiovasculares na população infectada pelo HIV eram relacionadas à imunossupressão. Entretanto, após o advento do uso combinado das drogas antirretrovirais, houve considerável diminuição na morbidade e na mortalidade desses pacientes. Porém, aparentemente,complicações metabólicas como resistência insulínica e dislipidemia passaram a ser mais frequentes nesses indivíduos, sugerindo aumento do risco de doença aterosclerótica. O objetivo deste artigo é rever a literatura e descrever as complicações cardiovasculares da infecção pelo HIV, com ênfase no período pós-terapia antirretroviral combinada. A revisão foi realizada dando destaque aos fatores de risco cardiovasculares e, principalmente, à doença cardíaca aterosclerótica e suas particularidades na população infectada pelo HIV...


Before high-power antiretroviral therapy was introduced, cardiovascular complications in the HIV-infected population were mainly related to immunosuppression. However, after the advent of combined use antiretroviral drugs the morbimortality of these patients decreased considerably. It seems, however, that metabolic complications such as insulin resistance and dyslipidemia have become more frequent, suggesting an increased risk of atherosclerotic disease. The purpose of this article is to review the literature and describe the cardiovascular complications related to HIV infection, with an emphasis on the period after combined antiretroviral therapy was introduced. The review was conducted to highlight the cardiovascular risk factors, mainly of atherosclerotic heart disease and its peculiarities among the HIV-infected population...


Subject(s)
Humans , Anti-Retroviral Agents/adverse effects , Coronary Artery Disease/complications , Risk Factors , HIV Infections/complications , Dyslipidemias , Biomarkers
SELECTION OF CITATIONS
SEARCH DETAIL